{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:03:32Z","timestamp":1790503412034,"version":"4.1.0"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"5","funder":[{"name":"Special Programme for Research and Training"},{"name":"Tropical Diseases (TDR)"},{"DOI":"10.13039\/100004423","name":"World Health Organization (WHO)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Research Foundation of South Africa","award":["90729"],"award-info":[{"award-number":["90729"]}]},{"name":"National Research Foundation of South Africa","award":["U01AI068636"],"award-info":[{"award-number":["U01AI068636"]}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health (NIMH)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research (NIDCR)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"crossref"}]},{"name":"United States Government Division of Tuberculosis Elimination"},{"name":"National Center for HIV"},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["AI69464"],"award-info":[{"award-number":["AI69464"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["ACTG 365, NCT00000877"],"award-info":[{"award-number":["ACTG 365, NCT00000877"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["521-2011-3442"],"award-info":[{"award-number":["521-2011-3442"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish National Infrastructure for Computing (SNIC) at UPPMAX"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1093\/jac\/dkv470","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T20:59:14Z","timestamp":1454360354000},"page":"1330-1340","source":"Crossref","is-referenced-by-count":14,"title":["Population pharmacokinetic drug\u2013drug interaction pooled analysis of existing data for rifabutin and HIV PIs"],"prefix":"10.1093","volume":"71","author":[{"given":"Stefanie","family":"Hennig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin M.","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Niebecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Bernard","family":"Fourie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc H.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Peloquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Gallicano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Flexner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Pym","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero L.","family":"Olliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McIlleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats O.","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,1,31]]},"reference":[{"key":"2016041309202593000_71.5.1330.1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-253"},{"key":"2016041309202593000_71.5.1330.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17141-9"},{"key":"2016041309202593000_71.5.1330.3","unstructured":"CDC. Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis . 22 September 2014. http:\/\/www.cdc.gov\/tb\/publications\/guidelines\/tb_hiv_drugs\/recommendations03.htm ."},{"key":"2016041309202593000_71.5.1330.4","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282faa71e"},{"key":"2016041309202593000_71.5.1330.5","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181642257"},{"key":"2016041309202593000_71.5.1330.6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.5.1553-1560.2004"},{"key":"2016041309202593000_71.5.1330.7","unstructured":"Grange S , Schutz M , Schmitt C et al . Unexpected hepatotoxicity observed in a healthy volunteer study on the effects of multiple dose rifampicin on the steady-state pharmacokinetics of ritonavir-boosted saquinavir and vice versa. In: Abstracts of the Sixth International Workshop on Clinical Pharmacology of HIV Therapy, Quebec, Canada, 2005 . Abstract 35, p. 27."},{"key":"2016041309202593000_71.5.1330.8","doi-asserted-by":"crossref","unstructured":"Rolla V , Vieira A , Pereira-Pinto D . Safety, efficacy and pharmacokinetics of ritonavir 400mg-saquinavir 400mg and rifampicin combined therapy in HIV patients with tuberculosis. In: Abstracts of the Third IAS Conference on HIV Pathogenesis and Treatment , Rio de Janeiro, Brazil, 2005. Abstract WePe3.3C0.","DOI":"10.2165\/00044011-200626080-00005"},{"key":"2016041309202593000_71.5.1330.9","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0144-3"},{"key":"2016041309202593000_71.5.1330.10","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1757"},{"key":"2016041309202593000_71.5.1330.11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.2.502-508.2001"},{"key":"2016041309202593000_71.5.1330.12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084866"},{"key":"2016041309202593000_71.5.1330.13","doi-asserted-by":"publisher","DOI":"10.1186\/2050-6511-15-61"},{"key":"2016041309202593000_71.5.1330.14","doi-asserted-by":"publisher","DOI":"10.1086\/606056"},{"key":"2016041309202593000_71.5.1330.15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070611"},{"key":"2016041309202593000_71.5.1330.16","unstructured":"Bonora S , Boffito M , D'Avolio A et al . Pharmacokinetics of rifabutin coadministered with lopinavir\/ritonavir in HIV patients affected by tuberculosis. In: Abstracts of the Second IAS Conference on HIV Pathogenesis and Treatment, Paris, France, 2003 . Abstract 863."},{"key":"2016041309202593000_71.5.1330.17","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.154.5.8912765"},{"key":"2016041309202593000_71.5.1330.18","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8479(94)90079-5"},{"key":"2016041309202593000_71.5.1330.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90036-4"},{"key":"2016041309202593000_71.5.1330.20","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku382"},{"key":"2016041309202593000_71.5.1330.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.08.003"},{"key":"2016041309202593000_71.5.1330.22","unstructured":"FDA. Label and Approval History: MYCOBUTIN . 2008."},{"key":"2016041309202593000_71.5.1330.23","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.Supplement_1.S15"},{"key":"2016041309202593000_71.5.1330.24","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2125.1999.00069.x","article-title":"Pharmacokinetics of rifabutin in HIV-infected patients with or without wasting syndrome","volume":"48","author":"Gatti","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"2016041309202593000_71.5.1330.25","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1128\/AAC.42.8.2017","article-title":"Population pharmacokinetics of rifabutin in human immunodeficiency virus-infected patients","volume":"42","author":"Gatti","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2016041309202593000_71.5.1330.26","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-006-0141-z"},{"key":"2016041309202593000_71.5.1330.27","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00461-07"},{"key":"2016041309202593000_71.5.1330.28","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6017(200002)89:2<155::AID-JPS3>3.0.CO;2-2"},{"key":"2016041309202593000_71.5.1330.29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200503-417OC"},{"key":"2016041309202593000_71.5.1330.30","doi-asserted-by":"publisher","DOI":"10.1086\/429321"},{"key":"2016041309202593000_71.5.1330.31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2002.01631.x"},{"key":"2016041309202593000_71.5.1330.32","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1999.0526"},{"key":"2016041309202593000_71.5.1330.33","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.6.793"},{"key":"2016041309202593000_71.5.1330.34","doi-asserted-by":"publisher","DOI":"10.1086\/496980"},{"key":"2016041309202593000_71.5.1330.35","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00724-07"},{"key":"2016041309202593000_71.5.1330.36","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.117612"},{"key":"2016041309202593000_71.5.1330.37","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2003.3"},{"key":"2016041309202593000_71.5.1330.38","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003262807"},{"key":"2016041309202593000_71.5.1330.39","doi-asserted-by":"publisher","DOI":"10.1086\/313771"},{"key":"2016041309202593000_71.5.1330.40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1128\/AAC.42.3.631","article-title":"Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers","volume":"42","author":"Hafner","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2016041309202593000_71.5.1330.41","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.5.1572-1577.2001"},{"key":"2016041309202593000_71.5.1330.42","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.8.2170-2172.2000"},{"key":"2016041309202593000_71.5.1330.43","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-6-199603150-00006"},{"key":"2016041309202593000_71.5.1330.44","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X167507"},{"key":"2016041309202593000_71.5.1330.45","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8479(05)80007-3"},{"key":"2016041309202593000_71.5.1330.46","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/32.6.867"},{"key":"2016041309202593000_71.5.1330.47","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8479(92)90077-W"},{"key":"2016041309202593000_71.5.1330.48","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8479(92)90081-T"},{"key":"2016041309202593000_71.5.1330.49","unstructured":"Agarwala S , Mummaneni V , Geraldes M et al . Pharmacokinetic effects of rifabutin on atazanavir with and without ritonavir in healthy subjects. In: Abstracts of the Ninth Conference on Retroviruses and Opportunistic Infections , Seattle, WA, USA, 2002. Foundation for Retrovirology and Human Health, Alexandria, VA, USA. Abstract 445-W."},{"key":"2016041309202593000_71.5.1330.50","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.8.1237"},{"key":"2016041309202593000_71.5.1330.51","unstructured":"NONMEM User's Guides (1989\u20132009), Version 7 . Ellicott City, MD, USA: Icon Development Solutions, 2009."},{"key":"2016041309202593000_71.5.1330.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2005.04.005"},{"key":"2016041309202593000_71.5.1330.53","doi-asserted-by":"crossref","unstructured":"Ette EI , Williams PJ , eds. Pharmacometrics: The Science of Quantitative Pharmacology . Hoboken, NJ, USA: John Wiley & Sons, 2007.","DOI":"10.1002\/0470087978"},{"key":"2016041309202593000_71.5.1330.54","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-011-9255-z"},{"key":"2016041309202593000_71.5.1330.55","unstructured":"Hennig S , Karlsson MO . Rifabutin and Darunavir\/RTV Drug-Drug Interaction Modelling and Simulation\u2014Report for Sponsor: Tibotec Pharmaceuticals, Belgium . Uppsala University, Uppsala, Sweden: Department of Pharmaceutical Biosciences, 2009."},{"key":"2016041309202593000_71.5.1330.56","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-014-9353-5"},{"key":"2016041309202593000_71.5.1330.57","doi-asserted-by":"publisher","DOI":"10.1007\/BF01113502"},{"key":"2016041309202593000_71.5.1330.58","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199630050-00001"},{"key":"2016041309202593000_71.5.1330.59","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200208-951OC"},{"key":"2016041309202593000_71.5.1330.60","unstructured":"Sekar V , Lavreys L , De Paepe E et al . Pharmacokinetic interaction between darunavir in combination with low-dose ritonavir and rifabutin. In: Abstracts of the Joint Meeting of the Forty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy and the Forty-sixth Meeting of the Infectious Diseases Society of America , Washington, DC, USA, 2008. Abstract H-4053."},{"key":"2016041309202593000_71.5.1330.61","unstructured":"Agouron Pharmaceuticals. Project RBD Analytical Report. HPLC Analysis of AG1343-523 in Human Plasma . 1996."},{"key":"2016041309202593000_71.5.1330.62","unstructured":"Ng J , Nada A , Freeman S et al . Pharmacokinetics of rifabutin 150 mg TIW plus LPV\/r 400\/100 mg BID administered in healthy adult subjects. In: Abstracts of the Tenth International Workshop on Clinical Pharmacology of HIV Therapy , Amsterdam, The Netherlands, 2009. Abstract O21."},{"key":"2016041309202593000_71.5.1330.63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03191.x"},{"key":"2016041309202593000_71.5.1330.64","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01195-15"},{"key":"2016041309202593000_71.5.1330.65","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0390"},{"key":"2016041309202593000_71.5.1330.66","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00534-08"},{"key":"2016041309202593000_71.5.1330.67","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01749-09"},{"key":"2016041309202593000_71.5.1330.68","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr266"},{"key":"2016041309202593000_71.5.1330.69","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00992-10"},{"key":"2016041309202593000_71.5.1330.70","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0222-8"},{"key":"2016041309202593000_71.5.1330.71","doi-asserted-by":"publisher","DOI":"10.1086\/518655"},{"key":"2016041309202593000_71.5.1330.72","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01988.x"},{"key":"2016041309202593000_71.5.1330.73","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746020-00004"},{"key":"2016041309202593000_71.5.1330.74","unstructured":"WHO. 19th WHO Model List of Essential Medicines (April 2015) . http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/EML2015_8-May-15.pdf?ua=1 ."}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/5\/1330\/13762475\/dkv470.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T01:36:14Z","timestamp":1567560974000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkv470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,31]]},"references-count":74,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,4,13]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1093\/jac\/dkv470"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkv470","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,31]]}}}